Back
Bicara Therapeutics, Inc. Stock Price Chart
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now
Sell
33
BCAX
Bicara Therapeutics, Inc.
Last Price:
$19.01
Seasonality Move:
-32.17%
7 Day Trial
ALL ACCESS PASS
$
7
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCAX is experiencing selling pressure, which indicates risk of future bearish movement.
Bicara Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.2 | Sell |
| 20-day SMA: | 16.59 | Buy |
| 50-day SMA: | 16.62 | Buy |
| 200-day SMA: | 13.03 | Buy |
| 8-day EMA: | 17.96 | Buy |
| 20-day EMA: | 17.18 | Buy |
| 50-day EMA: | 16.04 | Buy |
| 200-day EMA: | 13.44 | Buy |
Bicara Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 57.8 | Buy |
| Chaikin Money Flow: | -675548 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.57 - 18.03) | Buy |
| Bollinger Bands (100): | (11.09 - 16.91) | Buy |
Bicara Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Bicara Therapeutics, Inc. Stock
Is Bicara Therapeutics, Inc. Stock a Buy?
-
Bicara Therapeutics, Inc. share price is 18.20 while BCAX 8-day simple moving average is 18.20, which is a Sell signal.
-
The stock price of BCAX is 18.20 while Bicara Therapeutics, Inc. 20-day SMA is 16.59, which makes it a Buy.
-
Bicara Therapeutics, Inc. 50-day simple moving average is 16.62 while BCAX share price is 18.20, making it a Buy technically.
-
BCAX stock price is 18.20 and Bicara Therapeutics, Inc. 200-day simple moving average is 13.03, creating a Buy signal.
BCAX Technical Analysis vs Fundamental Analysis
Sell
33
Bicara Therapeutics, Inc. (BCAX)
is a Sell
Is Bicara Therapeutics, Inc. a Buy or a Sell?
-
Bicara Therapeutics, Inc. stock is rated a SellThe current Bicara Therapeutics, Inc. [BCAX] share price is $18.20. The Score for BCAX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Bicara Therapeutics, Inc. Stock Info
Market Cap:
997M
Price in USD:
18.20
Share Volume:
703.7K
Bicara Therapeutics, Inc. 52-Week Range
52-Week High:
22.68
52-Week Low:
7.80
Sell
33
Bicara Therapeutics, Inc. (BCAX)
is a Sell
Bicara Therapeutics, Inc. Share Price Forecast
-
What is the Bicara Therapeutics, Inc. stock price today?The Bicara Therapeutics, Inc. stock price is 18.20 USD today.
-
Will BCAX stock go up or go down?Bicara Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Bicara Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bicara Therapeutics, Inc. is overvalued.
Is Bicara Therapeutics, Inc. Stock a Buy?
-
Bicara Therapeutics, Inc. share price is 18.20 while BCAX 8-day exponential moving average is 17.96, which is a Buy signal.
-
The stock price of BCAX is 18.20 while Bicara Therapeutics, Inc. 20-day EMA is 17.18, which makes it a Buy.
-
Bicara Therapeutics, Inc. 50-day exponential moving average is 16.04 while BCAX share price is 18.20, making it a Buy technically.
-
BCAX stock price is 18.20 and Bicara Therapeutics, Inc. 200-day simple moving average is 13.44, creating a Buy signal.
Fundamental Analysis of Bicara Therapeutics, Inc.
Is Bicara Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.46 per share.
Technical Analysis of Bicara Therapeutics, Inc.
Should I short Bicara Therapeutics, Inc. stock?
-
BCAX Moving Average Covergence Divergence (MACD) indicator is 0.74, suggesting Bicara Therapeutics, Inc. is a Buy
-
Bicara Therapeutics, Inc. Relative Strength Index (RSI) is 57.8, which suggest Bicara Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Bicara Therapeutics, Inc. is (14.57 - 18.03), which suggest Bicara Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Bicara Therapeutics, Inc. is (11.09 - 16.91), which suggest Bicara Therapeutics, Inc. is a Buy
* Bicara Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.